Press Releases
July 30 2025
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
July 10 2025
InMode to Report Q2 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M
May 28 2025
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
May 20 2025
InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology
May 07 2025
InMode to Present at Upcoming Investor Conferences and Events
May 06 2025
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
April 28 2025
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
April 14 2025
InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M
March 26 2025
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
March 06 2025
InMode Responds to Doma Perpetual’s Letters
